EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Recurrent pituitary apoplexy: experience from a national registry and review of the literature

Betina Biagetti iD, Esteban Cordero Asanza, Pedro Iglesias, Rosa Camara, Queralt Asla, Almudena Vicente, Elena Martinez-Saez, Silvana Sarria-Estrada, Manel Puig-Domingo, Marta Araujo-Castro iD

Therapeutic Advances in Endocrinology and Metabolism · 2026-03 · 17

DOI: 10.1177/20420188261434641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 28.03.2026. Verfasst von Betina Biagetti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, ENDO-ERN, Pg. de la Vall d'Hebron, …. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pituitary apoplexy (PA) is a neuroendocrine emergency characterized by acute hemorrhage or infarction of a pituitary adenoma. While its initial presentation and management are well documented, data on recurrent PA remain scarce.

Objectives

To determine the prevalence, clinical characteristics, and predictors of recurrent PA in a national cohort, and to contextualize findings through a structured review of the literature.

Design

Multicenter retrospective cohort study complemented by a structured literature review.

Methods

We analyzed 274 patients from the Spanish Pituitary Apoplexy Registry (2010–2023) with complete follow-up. Recurrent PA was defined as a new acute episode with radiological evidence of hemorrhage or infarction within a previously affected lesion. Clinical, radiological, and treatment-related variables were compared between recurrent and non-recurrent cases. A complementary literature review identified published reports of recurrence.

Results

Recurrent PA occurred in 9 patients (3.3%), including 6 of 214 with nonfunctioning adenomas (2.8%) and 3 of 60 with functioning adenomas (5.0%). Compared with nonrecurrent cases, patients with recurrence had significantly larger tumors (median 35 vs 25 mm; p = 0.006), higher rates of cavernous sinus invasion (77.9% vs 37.3%; p = 0.006), and more frequent prior cabergoline therapy (33.3% vs 6.3%; p = 0.020). Median time to recurrence was 18 months (range, 2–108). The literature review identified 11 studies reporting recurrence rates of 2.6%–16.7%, with more consistent estimates (4%–9.6%) in larger series ( n ⩾ 50). All recurrent cases showed a favorable clinical course and recovery.

Conclusion

Recurrent PA is uncommon, affecting approximately 3% of patients with a prior apoplexy episode. Given the low frequency of recurrence, the associated factors identified should be interpreted cautiously and considered primarily hypothesis-generating. The second episode was not more severe than the initial event, and the long-term prognosis was favorable.

Trial registration

Not applicable.

Schlagwörter

Stichwörter der Autor:innen

apoplexyconservativepituitaryrecurrentrisk factorssurgery

Autor:innen und Institutionen

  • Endocrinology and Nutrition Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, ENDO-ERN, Pg. de la Vall d'Hebron, 119, Horta-Guinardó, Barcelona 08035, Spain.
  • Neurosurgery Department, Hospital Universitario Vall de Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain.
  • Department of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Endocrinology and Nutrition Service, La Fe University Hospital, Valencia, Spain.
  • Endocrinology and Nutrition Department, Hospital de la Santa Creu i Sant Pau, IR-SANTPAU, ENDO-ERN, Barcelona, Spain.

ORCID-Profile: Betina Biagetti, Marta Araujo-Castro

Zitieren

APA

Biagetti, B., Cordero Asanza, E., Iglesias, P., Camara, R., Asla, Q., Vicente, A., Martinez-Saez, E., Sarria-Estrada, S., Puig-Domingo, M., & Araujo-Castro, M. (2026). Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism, 17. https://doi.org/10.1177/20420188261434641

Vancouver

Biagetti B, Cordero Asanza E, Iglesias P, Camara R, Asla Q, Vicente A, et al. Recurrent pituitary apoplexy: experience from a national registry and review of the literature. Therapeutic Advances in Endocrinology and Metabolism. 2026;17. doi:10.1177/20420188261434641

BibTeX
@article{Biagetti2026,
  author = {Biagetti, Betina and Cordero Asanza, Esteban and Iglesias, Pedro and Camara, Rosa and Asla, Queralt and Vicente, Almudena and Martinez-Saez, Elena and Sarria-Estrada, Silvana and Puig-Domingo, Manel and Araujo-Castro, Marta},
  title = {Recurrent pituitary apoplexy: experience from a national registry and review of the literature},
  journal = {Therapeutic Advances in Endocrinology and Metabolism},
  year = {2026},
  volume = {17},
  doi = {10.1177/20420188261434641}
}
Kostenlos starten →